06:37 AM EDT, 07/06/2026 (MT Newswires) -- Clarivate ( CLVT ) has agreed to sell its Life Sciences & Healthcare segment to Altaris for $600 million in cash and notes, the company said Monday.

Under the terms of the deal, Clarivate ( CLVT ) will receive $500 million in cash at closing, $25 million in cash at the completion of a transition services agreement, and a $75 million seller note.

The deal is expected to close by the end of 2026, the company said.

Clarivate ( CLVT ) plans to use the cash proceeds to reduce debt and strengthen its balance sheet, it said.

After the transaction, Clarivate ( CLVT ) will become a subscription-based global provider of data, workflow software, and tech services for its academia and government and intellectual property segments, the company said.

Clarivate ( CLVT ) reaffirmed its full-year 2026 financial outlook, including adjusted EPS guidance of $0.70 to $0.80.